AzTrials
AzTrials

Preterm BirthNCT04247308

Multi Modal Stimulations in Pre-term Neonates

A study testing Sensory Stimulation, Movement therapy and Routine hospital care in people with Preterm Birth and Infant, Premature, Diseases, run by Asir John Samuel at 1 site in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A total of 56 neonates with LBW will recruited by the convenience sampling to participate in this two group pre-test post-test, single blinded randomized clinical study. After the demographics, recruited NLBW will be randomly divided into two groups, group A and group B with block randomization. Read more about this study

Who is it for?
Ages 2 to 28 days
Conditions the study is for
Preterm Birth, Infant, Premature, Diseases
What is being tested?
Sensory Stimulation, Movement therapy and Routine hospital care
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteIndia
Study dates
1 Oct 2020to 13 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants born between 28 and 36 week of gestation
  • Birth weight ranging from 1000-2500 g.
  • Medically stable preterm infants

Who cannot join

  • Medically unstable preterm infants.
  • Infants with congenital anomalies, congenital infections and central nervous system injury

Trial locations and contacts

1 site in 1 country.

India1 site
  • Neonatal Intensive Care Unit, Maharishi Markandeshwar Hospital

    Ambāla, Haryana, 133207

Other trials in India

About this study

Official title: Multi-modal Stimulations on Neuromotor Responses Among the Hospitalised Preterm Infants

A total of 56 neonates with LBW will recruited by the convenience sampling to participate in this two group pre-test post-test, single blinded randomized clinical study. After the demographics, recruited NLBW will be randomly divided into two groups, group A and group B with block randomization. There will be four blocks, with the matrix design of 4X14 here 14 being rows. Each block contained 4 chits (2 chits for each group), totalling 56. The subjects will be allotted to the group based on the randomly chosen chit by their parents. Once the block will be allotted, next row block was opened. Thus, equal number of NLBW will be assigned to each group over time.

Group A will be receiving multimodal sensory and kinesthetic stimulation (MSKS) and Group B will be receiving regular lifesaving hospital care. Group A will receive the interventions for 2 weeks period, totalling 10 sessions. Each session will last for 30 minutes duration.

Being tested
Sensory Stimulation, Movement therapy, Routine hospital care
Keywords
Preterm, Neonate, Multi-modal stimulation
Medical subject headings
Premature Birth, Infant, Premature, Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sensory StimulationOther

    Auditory, tactile, visual, vestibular and oro motor stimulation

  • Movement therapyOther

    Passive range of movements, antigravity movements in prone and supine

  • Routine hospital careOther

    Maintaining the vitals

Study groups in NCT04247308
Study groupRoleWhat they receive
experimental groupExperimentalSensory stimulations (ATVV) will be consisting of Soft lullaby between of 30-40 dB for Auditory, Gentle stroking massage in supine position(upper and lower limb)for Tactile, Visual Stimulations with Black and white card (distance of 8-10 in), gentle rocking (vertical and horizontal direction) for the stimulation of vestibular system and oral stimulation including stocking cheeks, lips, jaw and tongue, rubbing gum.Each stimulation will be given for 3 minutes. Movement therapy will include: Guided range of motion: flexion-extension movements of lower limb (bicycle riding pattern). Hand should be placed around knee joint. Care must be taken as PI consist the cartilaginous joints at wrist and ankle. Anti gravity movements in prone (neck and spinal extension), Anti gravity movements in sitting (supported) and Upright positioning for 3min each
Receives: Other: Sensory Stimulation; Other: Movement therapy
control groupActive comparatorreceives routine care from the nursing team as well as daily maternal care, such as being held in the mother's arms
Receives: Other: Routine hospital care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Infant Neurological International Battery

    Infant Neurological International Battery (INFANIB), the minimum and maximum values are 14 and 70 respectively, and higher scores mean a better outcome. Scores less than and equal to 48 is abnormal while greater than and equal to 66 means normal.

    Measured: Change from baseline and 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2020
  2. Study start1 Oct 2020
  3. Primary completion30 Oct 2021
  4. Study completion13 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two group pre-test post-test design
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04247308
Sponsor's protocol ID
MMDU/IEC/1566
Other IDs
U1111-1236-9478
Status last verified
Jan 2022
First submitted
28 Jan 2020
Last updated
20 Jan 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Publication in Peer-Reviewed Indexed Journals

Publications

  • Aranha VP, Chahal A, Bhardwaj AK. Neonatal aquatic physiotherapy in neonatal intensive care units: A scoping review. J Neonatal Perinatal Med. 2022;15(2):229-235. doi: 10.3233/NPM-210858.

    PubMed 34719445
  • Aranha VP, Chahal A, Bhardwaj AK. Short-term effects of multimodal stimulation on neuromotor behaviour and neonatal pain among hospitalized preterm infants: A feasibility, non-blinded randomized controlled trial. J Neonatal Perinatal Med. 2023;16(2):325-337. doi: 10.3233/NPM-210889.

    PubMed 34864695
  • Aranha VP, Chahal A, Bhardwaj AK. A randomized controlled trial protocol in modifying neuromotor behavior of hospitalized preterm neonates using multimodal stimulations: MMS trial. J Pediatr Rehabil Med. 2022;15(3):459-468. doi: 10.3233/PRM-200752.

    PubMed 35848042

Questions about this trial

What is this clinical trial studying?

A study testing Sensory Stimulation, Movement therapy and Routine hospital care in people with Preterm Birth and Infant, Premature, Diseases, run by Asir John Samuel at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Infant Neurological International Battery (time frame: Change from baseline and 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04247308, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in